Logo

CALL TOLL FREE TODAY

1.800.814.4540

Lawyers ⋅ Nurses ⋅ Doctors
Protecting Your Rights for Decades

Medical Devices Defective Drugs Transvaginal Mesh

Abilify

Plaintiffs allege Abilify (aripiprazole), an anti-psychotic medication prescribed to treat schizophrenia, bipolar disorder, depression, and Tourette syndrome, can cause compulsive gambling and other behaviors. 375 cases have been consolidated before Judge M. Casey Rodgers in the Northern District of Florida in MDL 2734, IN RE: Abilify (Aripiprazole) Products Liability Litigation.  Lawyers for the manufacturers, Otsuka Pharmaceutical and Bristol-Myers Squibb, have been ordered with settlement counsel to attend monthly settlement conferences

Compulsive Gambling

Plaintiffs allege that Abilify was defectively designed or manufactured, that the defendants knew or should have known of the propensity of Abilify to cause compulsive gambling behaviors in users, and that the defendants failed to provide adequate instructions and warnings with this product.

In 2002, Abilify was placed on the market and increases dopamine which tends to create uncontrollable urges and impairs decision-making skills. In 2012, after reports of 19 cases of “pathological gambling” in Europe, the manufacturers added a warning on the drug in Europe. In 2015, Canadian regulators concluded that there is “a link between the use of aripiprazole and a possible risk of pathological gambling or hypersexuality” and found an increased risk of pathological (uncontrollable) gambling and hypersexuality with the use of Abilify.”

FDA Warning Label Changed

In August 2016, warnings regarding compulsive gambling and other compulsive behaviors were added to the Abilify label. The label now warns that “[b]ecause patients may not recognize these behaviors as abnormal, it is important for prescribers to ask patients or their caregivers specifically about the development of new or intense gambling urges, compulsive sexual urges, compulsive shopping, binge or compulsive eating, or other urges while being treated with aripiprazole….Compulsive behaviors may result in harm to the patient and others if not recognized. Consider dose reduction or stopping the medication if a patient develops such urges.”

FDA Links Abilify to Compulsive Gambling, Eating, Shopping and Sex

If you or a loved one has exhibited compulsive behavior while taking Ability, contact us for a free medical legal consultation at 800-814-4540 or email carolyn@carolynstclair.com.

Share This Page: